logo
Testosterone gel: what happens if it rubs off on other people

Testosterone gel: what happens if it rubs off on other people

Yahoo2 days ago
A case that first appeared in a medical journal several years ago has recently resurfaced in the media, highlighting an unexpected risk of hormone therapies: a baby girl in Sweden developed unusually large genitals after lying on her father's bare chest, accidentally exposed to his testosterone gel.
The incident is a reminder that hormone treatments, while safe when used correctly, can pose risks to others if proper precautions aren't followed.
Testosterone is a powerful sex hormone that plays a crucial role in male development. In the early months of life, babies undergo rapid development, making their bodies, and hormones, extremely sensitive. Even small amounts of testosterone absorbed through the skin can affect a baby's development, particularly with repeated exposure.
Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences.
During 'mini-puberty' – a short surge in hormone levels occurring a few months after birth – boys experience rising testosterone levels that help complete reproductive system development and prime it for adulthood. This process also influences brain development.
In girls, oestrogen rises slightly during this period, but testosterone remains very low. When a girl is exposed to external testosterone, such as from hormone gel, it can cause unexpected changes, including enlarged clitoris or fusion of the labia. This is precisely what occurred in the Swedish case.
Testosterone gels are commonly prescribed to treat men with low testosterone deficiency. The gel is typically applied once daily to clean, dry skin on the shoulders, upper arms or stomach. These alcohol-based gels help the hormone absorb into the skin.
While the gel dries within minutes, residue can remain on the skin for an hour or two after application. If someone touches the treated area too soon, or rests directly on it, they can inadvertently absorb some of the hormone. This risk is particularly significant for babies and children, whose thinner, more absorbent skin and developing bodies make them more vulnerable.
Testosterone gels are also increasingly used off-label in women to treat menopause symptoms (such as low libido, low mood and fatigue) and at around one-tenth of the dose given to men. This lower dose is achieved by applying a smaller amount of the same male product — this time to the lower abdomen, buttocks or outer thighs.
This means there's much less hormone overall, but incidental exposure from women is also possible, for example, when holding a child soon after application.
Some perspective
While stories like this understandably cause concern, it's crucial to understand the actual risk level. In the UK, around 50,000 to 100,000 people are prescribed testosterone on the NHS, with gel formulations popular due to their ease of application. If accidental exposure were common, we would see far more cases than the small number reported in medical journals.
The instructions accompanying these gels are clear: apply only to specified areas, wash hands immediately, cover the skin once dry and avoid close skin contact for several hours. When these guidelines are followed, transfer is very unlikely.
In the case of the Swedish child, when the father stopped resting the baby on his bare chest, the genital changes reversed over time. This pattern holds true for other reported cases – if exposure stops early, many effects can fade naturally.
However, in more severe or prolonged cases, children may need medical treatment. This could include hormonal tests, continued monitoring, anti-hormone treatment, or even surgery if physical changes don't resolve. Early intervention is key, making it essential to consult a doctor if there's any concern.
For those with babies, young children, or pregnant partners at home, the solution is straightforward planning. Apply the gel when you won't be in direct contact immediately afterwards, or consider alternative application methods such as injections, skin patches, or tablets (available in the US), which carry lower risks of unintentional exposure to others.
This case serves as a valuable reminder that testosterone therapy, like all medications, comes with responsibilities. When used properly, it's an effective treatment for men with diagnosed testosterone deficiency, improving sexual function and mood, with evidence suggesting it can also support muscle mass, bone health, and metabolism.
There is no need to fear these treatments, but if you are prescribed this medication, use it responsibly and follow the instructions carefully.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Daniel Kelly does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Puraffinity and U.S. Army Corps of Engineers Partner to Advance PFAS Remediation Technologies
Puraffinity and U.S. Army Corps of Engineers Partner to Advance PFAS Remediation Technologies

Associated Press

timean hour ago

  • Associated Press

Puraffinity and U.S. Army Corps of Engineers Partner to Advance PFAS Remediation Technologies

US Army and Puraffinity will conduct a series of laboratory and field trials. LONDON, UNITED KINGDOM, July 20, 2025 / / -- Puraffinity, a leading innovator of advanced adsorbents for the removal of per- and polyfluorinated alkyl substances (PFAS), announces a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Engineer Research and Development Center (ERDC). The goal of the collaboration is to conduct research and field demonstrations involving Puraffinity's Puratech G400, an adsorbent material developed for the treatment of PFAS-contaminated waters. Under this agreement, ERDC and Puraffinity will conduct a series of laboratory and field trials. These trials will compare the performance of Puratech G400 with other PFAS treatment technologies such as Granular Activated Carbon (GAC) and Ion Exchange Resins (IEX). The primary objective is to explore Puratech G400's potential in improving treatment outcomes and reducing operating expenses (OPEX) and capital expenditure (CAPEX) in PFAS remediation. The research will target contamination sources from legacy facilities, including aqueous film-forming foams (AFFF). The key research objectives include: • Conducting laboratory and pilot-scale testing using real-world PFAS-contaminated water samples from both Department of Defense (DoD) and non-DoD sites. • Developing performance data to inform potential future applications on DoD installations and other settings. • Evaluating the use of Puratech G400 as a complementary or polishing step to existing destruction technologies. 'This collaboration with the ERDC marks a significant milestone in our mission to deliver innovative, scalable, and sustainable PFAS treatment technologies,' said Vincent Caillaud, CEO of Puraffinity. 'We are proud to work alongside one of the world's foremost research institutions to generate robust performance data and contribute meaningfully to the field of PFAS remediation.' The research initiative forms part of a broader strategic effort, reflecting Puraffinity's commitment to scientific rigor and collaborative innovation with government, industry, and academic stakeholders addressing the global PFAS challenge. Ade Alao Puraffinity [email protected] Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

James Webb telescope reveals 'Sleeping Beauty' galaxies in the early universe — snoozing where they weren't supposed to exist
James Webb telescope reveals 'Sleeping Beauty' galaxies in the early universe — snoozing where they weren't supposed to exist

Yahoo

time8 hours ago

  • Yahoo

James Webb telescope reveals 'Sleeping Beauty' galaxies in the early universe — snoozing where they weren't supposed to exist

When you buy through links on our articles, Future and its syndication partners may earn a commission. Astronomers have discovered over a dozen "dormant" galaxies that paused their star formation within the first billion years after the Big Bang. The discovery, made with data from the James Webb Space Telescope (JWST), illuminates a fascinating phase in the lives of early galaxies and could provide more clues about how galaxies evolve. There are several reasons why galaxies may stop forming new stars. One is the presence of supermassive black holes at their centers. These behemoths emit intense radiation that heats and depletes cold gas, the most important ingredient for star formation. Additionally, larger neighboring galaxies can strip away this cold gas or heat it, leading to a halt in star formation. As a result, these galaxies may remain dormant indefinitely, or become "quenched." Another reason galaxies become inactive is stellar feedback. That's when the gas in the galaxy gets warmed and expelled due to stellar processes like supernovas, intense stellar winds, or the pressure associated with starlight. The galaxy thus goes through a temporary "quiet" period. "This is usually a temporary phase, which usually lasts about 25 million years," Alba Covelo Paz, a doctoral student at the University of Geneva and the lead author of a new study describing the findings, told Live Science in an email. Over millions of years, the gas that was pushed out falls back in, and the warm gas cools again. Once there is enough cold gas again, the galaxy can start forming new stars. While the dormant phase is commonly observed in nearby galaxies, astronomers have found only four dormant galaxies in the first billion years of the universe. Of those, three had masses below a billion solar masses and one had a mass above 10 billion solar masses. The limited observations and scattered properties of dormant galaxies were not sufficient to get a clear picture of early star formation. Related: 'Previously unimaginable': James Webb telescope breaks its own record again, discovering farthest known galaxy in the universe But using JWST's sensitive spectroscopic data, an international team of astronomers discovered 14 dormant galaxies with a wide range of masses in the early universe, showing that dormant galaxies are not limited to low or very high mass ranges. The findings were uploaded to the preprint database arXiv on June 27 and have not been peer-reviewed yet. Taking a breather Researchers didn't expect to see dormant galaxies in the early universe. Because these galaxies are young, they should be vigorously forming many new stars, astronomers thought. But in a 2024 paper, researchers described the first discovery of a dormant galaxy in the early universe. "The first discovery of a dormant galaxy in the early universe was such a shock because that galaxy had been observed before with Hubble, but we could not know it was dormant until JWST," Paz said. That's because, unlike the Hubble Space Telescope, JWST's NIRSpec instrument can both see light from these galaxies that has been redshifted to near-infrared wavelengths, and also provide spectroscopic details about it. Astronomers were curious to know why early galaxies stopped forming stars and whether this was common among a wide range of stellar masses. One hypothesis was that the galaxies had bursts of star formation and then quiet periods, before starting again. Paz and her team looked for the galaxies that were in between bursts of star formation. They used publicly available galaxy data in the DAWN JWST Archive. They examined the light of about 1,600 galaxies, looking for signs of new stars not forming. They also focused on clear signatures of middle-aged or old stars in the galaxies' light. The team found 14 galaxies, ranging from about 40 million to 30 billion solar masses, that had paused star formation. "We now found 14 sources supporting this burstiness process, and we found that all of them have halted star formation between 10 [million] and 25 million years before we observed them," Paz explained. That means these 14 galaxies were found to follow a stop-and-go fashion of star formation rather than continuously forming stars, and they have been quiet for at least 10 million to 25 million years. This relatively short snooze hints that stellar feedback, such as supernovas or stellar winds, caused them to go quiet and that they may eventually restart their stellar factories, Paz said. However, there is still uncertainty, she added. "We cannot confirm it for sure because we don't know how long they will remain dormant, and if they happen to stay dormant for another 50 million years, this would mean the cause of their quenching is different," Paz explained. RELATED STORIES —Interstellar comet 3I/ATLAS transforms into a giant 'cosmic rainbow' in trippy new telescope image —'Ice cube' clouds discovered at the galaxy's center shouldn't exist — and they hint at a recent black hole explosion —Behold, 'The Beast': Gigantic animal-like plasma plume 13 times wider than Earth hovers over the sun This scenario would suggest that the galaxies are dead. Nevertheless, the current properties of these galaxies support a cycle of fits and starts. Because dormant galaxies are so rare, much about them remains mysterious. However, astronomers hope future observations will help shed light on these snoozing star factories. An upcoming JWST program called "Sleeping Beauties" will be dedicated to discovering dormant galaxies in the early universe, Paz said. This program will allow astronomers to estimate how long a galaxy remains in this quiet phase and help them understand the bursty star formation process. "There are still many unknowns for us, but we are one step closer to unravelling this process," Paz said.

Slovenia approves law to legalize assisted dying for terminally-ill adults
Slovenia approves law to legalize assisted dying for terminally-ill adults

Yahoo

time13 hours ago

  • Yahoo

Slovenia approves law to legalize assisted dying for terminally-ill adults

Slovenian lawmakers became the first Eastern European country to legalize a law on Friday to allow medically-assisted suicide for terminally-ill adults, in a shift in regional end-of-life policy. The country's lawmakers passed the bill following a closely watched parliamentary vote with 50 votes in favor, 34 against and three abstaining. The vote also focused on a national referendum demanding expanded end-of-life rights. The legislation comes after a consultative referendum last year in which 55% of voters supported the right to end-of-life autonomy. While the move is being praised as historic, the law's implementation will not be immediate as the procedures and oversight mechanisms are still being developed. The law applies to terminally ill adults who are experiencing unbearable suffering with no prospect of improvement. In order for candidates to qualify, they must be mentally competent and have already exhausted their available treatment options. Individuals suffering solely from mental illness will be excluded from eligibility. The patient has to provide informed, voluntary, and repeated consent. It is believed that the process may require evaluation by multiple medical professionals. Delaware's Assisted Suicide Bill Signed Into Law, Making It The 11Th State With Such A Statute Although it is being hailed as a landmark move, it will not be immediately implemented as the detailed procedures and oversight mechanisms are still being finalized. Read On The Fox News App "This is a victory for compassion and dignity," said one lawmaker in support of the bill. A civil rights group opposed to the law referendum to overturn the measure. A civil rights group opposing the new law pledged on Friday to seek public backing for a potential attempt to force a referendum on the measure. New York Assembly Passes Bill To Legalize Assisted Suicide For The Terminally Ill Several other countries, including Canada, Germany, Belgium, Switzerland, the Netherlands, Australia and Colombia, have legalized the so-called death with dignity. Last month, Britain's parliament voted to legalize assisted dying, although the bill must still clear the upper chamber of parliament. In the U.S., 11 states allow medical aid in dying: Delaware, California, Colorado, Hawaii, Maine, Montana, New Jersey, New Mexico, Oregon, Vermont and Washington. Lawmakers in some other states are considering similar legislation. Washington, D.C., also permits physician-assisted suicide. Reuters contributed to this article source: Slovenia approves law to legalize assisted dying for terminally-ill adults Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store